Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104471152 | 10447115 | 2 | F | 20160630 | 20140911 | 20160705 | EXP | PHHY2014VE112439 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160705 | CN | COUNTRY NOT SPECIFIED | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104471152 | 10447115 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, DAILY | 22334 | 10 | MG | QD | |||||||
| 104471152 | 10447115 | 2 | C | AROMASIN | EXEMESTANE | 1 | Unknown | 25 MG, UNK | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104471152 | 10447115 | 1 | Breast cancer |
| 104471152 | 10447115 | 2 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104471152 | 10447115 | HO |
| 104471152 | 10447115 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104471152 | 10447115 | Aphonia | |
| 104471152 | 10447115 | Bacterial infection | |
| 104471152 | 10447115 | Blood glucose increased | |
| 104471152 | 10447115 | Breast cancer | |
| 104471152 | 10447115 | Hypersensitivity | |
| 104471152 | 10447115 | Influenza | |
| 104471152 | 10447115 | Nephrolithiasis | |
| 104471152 | 10447115 | Pain | |
| 104471152 | 10447115 | Thyroid disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104471152 | 10447115 | 1 | 201403 | 0 |